Use of an epidermal growth factor receptor kinase inhibitor (EGFR) in gefitinib resistant patients

Details for Australian Patent Application No. 2006236940 (hide)

Owner Wyeth

Inventors Greenberger, Lee; Lundberg, Ante (Bill); Zacharchuk, Charles M; Quinn, Susan E.; Martins, Patricia

Agent Davies Collison Cave

Pub. Number AU-A-2006236940

PCT Pub. Number WO2006/113151

Priority 60/671,287 14.04.05 US

Filing date 7 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113151 Priority application(s): WO2006/113151

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236944-High density coaxial switching jack

2006236939-Niacin receptor agonists, compositions containing such compounds and methods of treatment